Keensight Capital, a European growth buyout investor with expertise in technology and healthcare, has inked an agreement to invest in Symeres- a prominent European drug discovery Contract Development and Manufacturing

Ola Foundation and GiveIndia have formed a new partnership to bring COVID-19 relief to India. The initiative will deliver free O2 concentrators to

Indian multinational cooperation- Wipro has announced a partnership with Transcell Oncologics in a bid to enhance vaccine safety assessment with the help of augmented intelligence. The alliance integrates Transcell&rsq

German specialty life sciences company Revive Therapeutics Ltd has reportedly inked a sponsored research agreement with University of California, San Francisco (UCSF). This agreement is geared towards exploring the pot

Aiming to reduce tobacco-smoking related diseases and death significantly, the US Food and Drug Administration (FDA) is reportedly planning to enforce a ban on all flavored cigars, including menthol flavored ones, and

Research teams Mintota and Photochemistry Reactivity Group, a part of the faculties of Chemistry and Pharmacy, University of Valencia have reportedly developed a solution to detect kidney cancer through urine along wit

First 10 patients administered in 77 patients placebo controlled, randomized Phase 1 trial at Jerusalem’s Shaare Zedek Medical Center With COVID-19 cases rea

U.S-based Lyndra Therapeutics, a clinical-stage biotech firm focused on making pills a thing of the past, has recently announced the results from its Phase 2 study of LYN-005, its oral ER risperidone capsule. For the r

Adlai Nortye, one of the leading biopharmaceutical companies of China, has recently announced dosing its first patient in the global phase 3 clinical trial (BURAN) at Shanghai Eastern Hospital Center in the country.